SUPPORT Generics giant Teva will fund ACS grants for newly tenured faculty

Abstract

The U.S. branch of generic pharmaceutical giant Teva Pharmaceutical Industries is providing ACS with all required funding to establish a philanthropic grant program to support academic researchers in organic and medicinal chemistry. The new Teva USA Scholars grants will be administered by the ACS Office of Research Grants, which also manages the ACS Petroleum Research Fund. The program will award three grants, each consisting of $100,000 per year for three years, to three faculty members in Ph.D.-granting departments at institutions in the U.S. Recipients must have earned tenure within four years of the date of receipt of their applications. Successful results of work supported by the Teva grants would be expected to advance the discovery of organic compounds useful for human medicines. “This program fills a niche in the chemistry community that can’t be filled by the Petroleum Research Fund,” says W. Christopher Hollinsed, director of the ACS Office of Research Grants. “There are many ...